<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reduced expression of E-cadherin, a Ca(2+)-dependent cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule present in <z:mpath ids='MPATH_458'>normal</z:mpath> epithelium, has been associated with invasive and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Immunohistochemistry was used in examining the relationship between E-cadherin expression and stage in 59 oesophageal and 52 lung <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Advanced-stage <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancers</z:e> were associated with both reduced and disorganised E-cadherin expression (P &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Advanced-stage <z:mp ids='MP_0002027'>lung adenocarcinomas</z:mp> generally exhibited disorganised or reduced E-cadherin expression, but no statistical association between expression pattern and stage was found (P &gt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>No differences in stage were seen between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with reduced or disorganised E-cadherin expression </plain></SENT>
<SENT sid="5" pm="."><plain>Altered E-cadherin expression was detected in dysplastic, non-invasive <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, high-level E-cadherin expression was detected in 17 of 17 lymph nodes containing <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>E-cadherin <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was decreased in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with reduced protein expression, but not in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with disorganised expression </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of alpha-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi>, an E-cadherin-associated protein, was detected in tissues with altered E-cadherin protein expression </plain></SENT>
<SENT sid="9" pm="."><plain>Reduced and disorganised expression of E-cadherin appear to be related to transcriptional and post-translational events respectively, and both appear to represent altered cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> associated with invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in thoracic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>